img

Global Ertapenem API Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 90 | Industry : Pharma & Healthcare

Publisher : Q | Format : PDF

Global Ertapenem API Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Above 98%
Above 99%


Segment by Application


Injection
Table
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE




By Company


Kopran (Parijat Enterprises)
Canagen Pharmaceuticals Inc
Conderco
Taiwan Savior Lifetec Corporation
Taiwan Grene Biotechnology
Xiamen Amoipharm
Chongqing Fuan Pharmaceutical
ACS Dobfar

Table of Content

1 Ertapenem API Market Overview
1.1 Product Overview and Scope of Ertapenem API
1.2 Ertapenem API Segment by Type
1.2.1 Global Ertapenem API Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Above 98%
1.2.3 Above 99%
1.3 Ertapenem API Segment by Application
1.3.1 Ertapenem API Sales Comparison by Application: (2021-2027)
1.3.2 Injection
1.3.3 Table
1.3.4 Others
1.4 Global Ertapenem API Market Size Estimates and Forecasts
1.4.1 Global Ertapenem API Revenue 2016-2027
1.4.2 Global Ertapenem API Sales 2016-2027
1.4.3 Ertapenem API Market Size by Region: 2016 Versus 2021 Versus 2027

2 Ertapenem API Market Competition by Manufacturers
2.1 Global Ertapenem API Sales Market Share by Manufacturers (2016-2021)
2.2 Global Ertapenem API Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Ertapenem API Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Ertapenem API Manufacturing Sites, Area Served, Product Type
2.5 Ertapenem API Market Competitive Situation and Trends
2.5.1 Ertapenem API Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Ertapenem API Players Market Share by Revenue
2.5.3 Global Ertapenem API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Ertapenem API Retrospective Market Scenario by Region
3.1 Global Ertapenem API Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Ertapenem API Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Ertapenem API Market Facts & Figures by Country
3.3.1 North America Ertapenem API Sales by Country
3.3.2 North America Ertapenem API Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Ertapenem API Market Facts & Figures by Country
3.4.1 Europe Ertapenem API Sales by Country
3.4.2 Europe Ertapenem API Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ertapenem API Market Facts & Figures by Region
3.5.1 Asia Pacific Ertapenem API Sales by Region
3.5.2 Asia Pacific Ertapenem API Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Ertapenem API Market Facts & Figures by Country
3.6.1 Latin America Ertapenem API Sales by Country
3.6.2 Latin America Ertapenem API Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Ertapenem API Market Facts & Figures by Country
3.7.1 Middle East and Africa Ertapenem API Sales by Country
3.7.2 Middle East and Africa Ertapenem API Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Ertapenem API Historic Market Analysis by Type
4.1 Global Ertapenem API Sales Market Share by Type (2016-2021)
4.2 Global Ertapenem API Revenue Market Share by Type (2016-2021)
4.3 Global Ertapenem API Price by Type (2016-2021)

5 Global Ertapenem API Historic Market Analysis by Application
5.1 Global Ertapenem API Sales Market Share by Application (2016-2021)
5.2 Global Ertapenem API Revenue Market Share by Application (2016-2021)
5.3 Global Ertapenem API Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Kopran (Parijat Enterprises)
6.1.1 Kopran (Parijat Enterprises) Corporation Information
6.1.2 Kopran (Parijat Enterprises) Description and Business Overview
6.1.3 Kopran (Parijat Enterprises) Ertapenem API Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Kopran (Parijat Enterprises) Product Portfolio
6.1.5 Kopran (Parijat Enterprises) Recent Developments/Updates
6.2 Canagen Pharmaceuticals Inc
6.2.1 Canagen Pharmaceuticals Inc Corporation Information
6.2.2 Canagen Pharmaceuticals Inc Description and Business Overview
6.2.3 Canagen Pharmaceuticals Inc Ertapenem API Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Canagen Pharmaceuticals Inc Product Portfolio
6.2.5 Canagen Pharmaceuticals Inc Recent Developments/Updates
6.3 Conderco
6.3.1 Conderco Corporation Information
6.3.2 Conderco Description and Business Overview
6.3.3 Conderco Ertapenem API Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Conderco Product Portfolio
6.3.5 Conderco Recent Developments/Updates
6.4 Taiwan Savior Lifetec Corporation
6.4.1 Taiwan Savior Lifetec Corporation Corporation Information
6.4.2 Taiwan Savior Lifetec Corporation Description and Business Overview
6.4.3 Taiwan Savior Lifetec Corporation Ertapenem API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Taiwan Savior Lifetec Corporation Product Portfolio
6.4.5 Taiwan Savior Lifetec Corporation Recent Developments/Updates
6.5 Taiwan Grene Biotechnology
6.5.1 Taiwan Grene Biotechnology Corporation Information
6.5.2 Taiwan Grene Biotechnology Description and Business Overview
6.5.3 Taiwan Grene Biotechnology Ertapenem API Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Taiwan Grene Biotechnology Product Portfolio
6.5.5 Taiwan Grene Biotechnology Recent Developments/Updates
6.6 Xiamen Amoipharm
6.6.1 Xiamen Amoipharm Corporation Information
6.6.2 Xiamen Amoipharm Description and Business Overview
6.6.3 Xiamen Amoipharm Ertapenem API Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Xiamen Amoipharm Product Portfolio
6.6.5 Xiamen Amoipharm Recent Developments/Updates
6.7 Chongqing Fuan Pharmaceutical
6.6.1 Chongqing Fuan Pharmaceutical Corporation Information
6.6.2 Chongqing Fuan Pharmaceutical Description and Business Overview
6.6.3 Chongqing Fuan Pharmaceutical Ertapenem API Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Chongqing Fuan Pharmaceutical Product Portfolio
6.7.5 Chongqing Fuan Pharmaceutical Recent Developments/Updates
6.8 ACS Dobfar
6.8.1 ACS Dobfar Corporation Information
6.8.2 ACS Dobfar Description and Business Overview
6.8.3 ACS Dobfar Ertapenem API Sales, Revenue and Gross Margin (2016-2021)
6.8.4 ACS Dobfar Product Portfolio
6.8.5 ACS Dobfar Recent Developments/Updates

7 Ertapenem API Manufacturing Cost Analysis
7.1 Ertapenem API Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ertapenem API
7.4 Ertapenem API Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ertapenem API Distributors List
8.3 Ertapenem API Customers

9 Ertapenem API Market Dynamics
9.1 Ertapenem API Industry Trends
9.2 Ertapenem API Growth Drivers
9.3 Ertapenem API Market Challenges
9.4 Ertapenem API Market Restraints

10 Global Market Forecast
10.1 Ertapenem API Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ertapenem API by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Ertapenem API by Type (2022-2027)
10.2 Ertapenem API Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ertapenem API by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Ertapenem API by Application (2022-2027)
10.3 Ertapenem API Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ertapenem API by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Ertapenem API by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Ertapenem API Sales (Ton) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Ertapenem API Sales (Ton) Comparison by Application (2021-2027)
Table 3. Global Ertapenem API Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Ertapenem API Covered in This Study
Table 5. Global Ertapenem API Sales (Ton) of Key Manufacturers (2016-2021)
Table 6. Global Ertapenem API Sales Share by Manufacturers (2016-2021)
Table 7. Global Ertapenem API Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Ertapenem API Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Ertapenem API Average Price (US$/Ton) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Ertapenem API Manufacturing Sites and Area Served
Table 11. Manufacturers Ertapenem API Product Type
Table 12. Global Ertapenem API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Ertapenem API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ertapenem API as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Ertapenem API Sales by Region (2016-2021) & (Ton)
Table 16. Global Ertapenem API Sales Market Share by Region (2016-2021)
Table 17. Global Ertapenem API Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Ertapenem API Sales by Country (2016-2021) & (Ton)
Table 19. North America Ertapenem API Sales Market Share by Country (2016-2021)
Table 20. North America Ertapenem API Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Ertapenem API Revenue Market Share by Country (2016-2021)
Table 22. Europe Ertapenem API Sales by Country (2016-2021) & (Ton)
Table 23. Europe Ertapenem API Sales Market Share by Country (2016-2021)
Table 24. Europe Ertapenem API Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Ertapenem API Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Ertapenem API Sales by Region (2016-2021) & (Ton)
Table 27. Asia Pacific Ertapenem API Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Ertapenem API Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Ertapenem API Revenue Market Share by Region (2016-2021)
Table 30. Latin America Ertapenem API Sales by Country (2016-2021) & (Ton)
Table 31. Latin America Ertapenem API Sales Market Share by Country (2016-2021)
Table 32. Latin America Ertapenem API Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Ertapenem API Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Ertapenem API Sales by Country (2016-2021) & (Ton)
Table 35. Middle East and Africa Ertapenem API Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Ertapenem API Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Ertapenem API Revenue Market Share by Country (2016-2021)
Table 38. Global Ertapenem API Sales (Ton) by Type (2016-2021)
Table 39. Global Ertapenem API Sales Market Share by Type (2016-2021)
Table 40. Global Ertapenem API Revenue (Million US$) by Type (2016-2021)
Table 41. Global Ertapenem API Revenue Share by Type (2016-2021)
Table 42. Global Ertapenem API Price (US$/Ton) by Type (2016-2021)
Table 43. Global Ertapenem API Sales (Ton) by Application (2016-2021)
Table 44. Global Ertapenem API Sales Market Share by Application (2016-2021)
Table 45. Global Ertapenem API Revenue (Million US$) by Application (2016-2021)
Table 46. Global Ertapenem API Revenue Share by Application (2016-2021)
Table 47. Global Ertapenem API Price (US$/Ton) by Application (2016-2021)
Table 48. Kopran (Parijat Enterprises) Corporation Information
Table 49. Kopran (Parijat Enterprises) Description and Business Overview
Table 50. Kopran (Parijat Enterprises) Ertapenem API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 51. Kopran (Parijat Enterprises) Ertapenem API Product
Table 52. Kopran (Parijat Enterprises) Recent Developments/Updates
Table 53. Canagen Pharmaceuticals Inc Corporation Information
Table 54. Canagen Pharmaceuticals Inc Description and Business Overview
Table 55. Canagen Pharmaceuticals Inc Ertapenem API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 56. Canagen Pharmaceuticals Inc Ertapenem API Product
Table 57. Canagen Pharmaceuticals Inc Recent Developments/Updates
Table 58. Conderco Corporation Information
Table 59. Conderco Description and Business Overview
Table 60. Conderco Ertapenem API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 61. Conderco Ertapenem API Product
Table 62. Conderco Recent Developments/Updates
Table 63. Taiwan Savior Lifetec Corporation Corporation Information
Table 64. Taiwan Savior Lifetec Corporation Description and Business Overview
Table 65. Taiwan Savior Lifetec Corporation Ertapenem API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 66. Taiwan Savior Lifetec Corporation Ertapenem API Product
Table 67. Taiwan Savior Lifetec Corporation Recent Developments/Updates
Table 68. Taiwan Grene Biotechnology Corporation Information
Table 69. Taiwan Grene Biotechnology Description and Business Overview
Table 70. Taiwan Grene Biotechnology Ertapenem API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 71. Taiwan Grene Biotechnology Ertapenem API Product
Table 72. Taiwan Grene Biotechnology Recent Developments/Updates
Table 73. Xiamen Amoipharm Corporation Information
Table 74. Xiamen Amoipharm Description and Business Overview
Table 75. Xiamen Amoipharm Ertapenem API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 76. Xiamen Amoipharm Ertapenem API Product
Table 77. Xiamen Amoipharm Recent Developments/Updates
Table 78. Chongqing Fuan Pharmaceutical Corporation Information
Table 79. Chongqing Fuan Pharmaceutical Description and Business Overview
Table 80. Chongqing Fuan Pharmaceutical Ertapenem API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 81. Chongqing Fuan Pharmaceutical Ertapenem API Product
Table 82. Chongqing Fuan Pharmaceutical Recent Developments/Updates
Table 83. ACS Dobfar Corporation Information
Table 84. ACS Dobfar Description and Business Overview
Table 85. ACS Dobfar Ertapenem API Sales (Ton), Revenue (Million US$), Price (US$/Ton) and Gross Margin (2016-2021)
Table 86. ACS Dobfar Ertapenem API Product
Table 87. ACS Dobfar Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Ertapenem API Distributors List
Table 91. Ertapenem API Customers List
Table 92. Ertapenem API Market Trends
Table 93. Ertapenem API Growth Drivers
Table 94. Ertapenem API Market Restraints
Table 95. Global Ertapenem API Sales Forecast by Type (2022-2027) & (Ton)
Table 96. Global Ertapenem API Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Ertapenem API Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Ertapenem API Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Ertapenem API Sales Forecast by Application (2022-2027) & (Ton)
Table 100. Global Ertapenem API Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Ertapenem API Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Ertapenem API Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Ertapenem API Sales Forecast by Region (2022-2027) & (Ton)
Table 104. Global Ertapenem API Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Ertapenem API Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Ertapenem API Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ertapenem API
Figure 2. Global Ertapenem API Market Share by Type in 2020 & 2027
Figure 3. Above 98% Product Picture
Figure 4. Above 99% Product Picture
Figure 5. Global Ertapenem API Market Share by Application in 2020 & 2027
Figure 6. Injection
Figure 7. Table
Figure 8. Others
Figure 9. Global Ertapenem API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Ertapenem API Market Size 2016-2027 (US$ Million)
Figure 11. Global Ertapenem API Sales 2016-2027 (Ton)
Figure 12. Global Ertapenem API Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Ertapenem API Sales Share by Manufacturers in 2020
Figure 14. Global Ertapenem API Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Ertapenem API Players: Market Share by Revenue in 2020
Figure 16. Ertapenem API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Ertapenem API Sales Market Share by Region (2016-2021)
Figure 18. Global Ertapenem API Sales Market Share by Region in 2020
Figure 19. Global Ertapenem API Revenue Market Share by Region (2016-2021)
Figure 20. Global Ertapenem API Revenue Market Share by Region in 2020
Figure 21. U.S. Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Ertapenem API Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Ertapenem API by Type (2016-2021)
Figure 46. Sales Market Share of Ertapenem API by Application (2016-2021)
Figure 47. Sales Market Share of Ertapenem API by Application in 2020
Figure 48. Revenue Share of Ertapenem API by Application (2016-2021)
Figure 49. Revenue Share of Ertapenem API by Application in 2020
Figure 50. Manufacturing Cost Structure of Ertapenem API
Figure 51. Manufacturing Process Analysis of Ertapenem API
Figure 52. Ertapenem API Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed